Bay 13-9952, an inhibitor of the microsomal triglyceride transfer protein (MTP), dose-dependently blacks the formation of atherosclerotic plaques and renders them more stable in ApoE knockout mice

被引：0

|

作者：

Zaiss, S ^{[1
]}

Gruetzmann, R ^{[1
]}

Ulrich, M ^{[1
]}

机构：

[1] Bayer AG, D-5600 Wuppertal, Germany

来源：

CIRCULATION | 1999年 / 100卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1343

引用

收藏

页码：258 / 258

页数：1

相关论文

共 4 条

[1] Bay 13-9952 (implitapide), an inhibitor of the microsomal triglyceride transfer protein (MTP), inhibits atherosclerosis and prolongs lifetime in apo-E knockout mice
Zaiss, S
Sander, E
EUROPEAN HEART JOURNAL, 2000, 21 : 16 - 16
[2] Bay 13-9952, an inhibitor of the microsomal triglyceride transfer protein (MTP), inhibits atherosclerotic plaque formation in cholesterol-fed rabbits in spite of a concomitant reduction of vitamin E
Zaiss, S
Gruetzmann, R
Mueller, U
CIRCULATION, 1999, 100 (18) : 258 - 258
[3] BAY 13-9952 (implitapide): pharmacodynamic effects of a new microsomal triglyceride transfer protein (MTP) inhibitor on plasma lipids and adipose tissue in animals
Bischoff, H
Denzer, D
EUROPEAN HEART JOURNAL, 2000, 21 : 636 - 636
[4] Implitapide (BAY 13-9952) inhibits secretion of apoB-associated lipoproteins by inhibition of the microsomal triglyceride transfer protein (MTP)
Gruetzmann, R
Beuck, M
Nielsch, U
Mueller, U
EUROPEAN HEART JOURNAL, 2000, 21 : 600 - 600